ALLOPURINOL-ENHANCED POSTISCHEMIC RECOVERY IN THE ISOLATED PAT HEART INVOLVES REPLETION OF HIGH-ENERGY PHOSPHATES

被引:15
作者
PISARENKO, OI
LAKOMKIN, VL
STUDNEVA, IM
TIMOSHIN, AA
KUZMIN, AI
RUUGE, EK
KAPELKO, VI
机构
[1] Acad Med Sci, Inst Exptl Cardiol, Cardiol Res Ctr, 3rd Cherepkovskaya St 15A
来源
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1994年 / 51卷 / 01期
关键词
D O I
10.1006/bmmb.1994.1002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of allopurinol (AP) on functional and metabolic recovery of the isolated rat heart after global ischemia were studied. Hearts were subjected to aerobic perfusion (30 min), cardioplegic infusion (5 min), normothermic ischemia (37 min), and reperfusion (50 min) which was started with secondary cardioplegic infusion (10 min). AP was injected into rats (44 mg/kg body wt ip 2 h before heart excision) and added to cardioplegic solution (2 mM) prior and after ischemia. AP treatment significantly improved postischemic recovery of the function and reduced the leakage of lactate dehydrogenase from reperfused hearts. These beneficial effects were accompanied by a better preservation of tissue content of ATP, the total adenine nucleotides, phosphocreatine, and the total creatine at the end of reperfusion. Inhibition of xanthine oxidase by AP substantially de creased pre- and postischemic release of xanthine and uric acid and increased postischemic release of hypoxanthine into the coronary effluent. Despite this, AP treated hearts did not exhibit a reduction in hydroxyl radical adduct formation in the effluents at reperfusion assessed by the spin-trap measurements. The results suggest that AP may protect the heart from ischemia/reperfusion injury due to enhanced energy provision rather than by prevention of oxygen-derived free radical formation. (C) 1994 Academic Press, Inc.
引用
收藏
页码:16 / 26
页数:11
相关论文
共 70 条
[1]   INFARCT SIZE LIMITATION BY THE XANTHINE-OXIDASE INHIBITOR, ALLOPURINOL, IN CLOSED-CHEST DOGS WITH SMALL INFARCTS [J].
AKIZUKI, S ;
YOSHIDA, S ;
CHAMBERS, DE ;
EDDY, LJ ;
PARMLEY, LF ;
YELLON, DM ;
DOWNEY, JM .
CARDIOVASCULAR RESEARCH, 1985, 19 (11) :686-692
[2]   MYOCARDIAL REPERFUSION INJURY - MECHANISMS AND MANAGEMENT - A REVIEW [J].
AMBROSIO, G ;
CHIARIELLO, M .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S86-S88
[3]   THE EFFECT OF ALLOPURINOL ON THE DEGREE OF EARLY MYOCARDIAL ISCHEMIA [J].
ARNOLD, WL ;
DEWALL, RA ;
KEZDI, P ;
ZWART, HHJ .
AMERICAN HEART JOURNAL, 1980, 99 (05) :614-624
[4]  
BANDO K, 1988, J THORAC CARDIOV SUR, V95, P465
[5]  
BERGMEYER HU, 1974, METHOD ENZYMAT AN, P574
[6]   REPERFUSION ARRHYTHMIAS - DOSE-RELATED PROTECTION BY ANTI-FREE RADICAL INTERVENTIONS [J].
BERNIER, M ;
MANNING, AS ;
HEARSE, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (05) :H1344-H1352
[7]  
Bernt E., 1974, METHOD ENZYMAT AN, P1772
[8]   XANTHINE-OXIDASE PRODUCES HYDROGEN-PEROXIDE WHICH CONTRIBUTES TO REPERFUSION INJURY OF ISCHEMIC, ISOLATED, PERFUSED RAT HEARTS [J].
BROWN, JM ;
TERADA, LS ;
GROSSO, MA ;
WHITMANN, GJ ;
VELASCO, SE ;
PATT, A ;
HARKEN, AH ;
REPINE, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (04) :1297-1301
[9]   FREE-RADICALS AND CARDIOPLEGIA - ALLOPURINOL AND OXYPURINOL REDUCE MYOCARDIAL INJURY FOLLOWING ISCHEMIC ARREST [J].
CHAMBERS, DJ ;
BRAIMBRIDGE, MV ;
HEARSE, DJ .
ANNALS OF THORACIC SURGERY, 1987, 44 (03) :291-297
[10]   ALLOPURINOL-ENHANCED MYOCARDIAL PROTECTION DOES NOT INVOLVE XANTHINE-OXIDASE INHIBITION OR PURINE SALVAGE [J].
CHAMBERS, DJ ;
TAKAHASHI, A ;
HUMPHREY, SM ;
HARVEY, DM ;
HEARSE, DJ .
BASIC RESEARCH IN CARDIOLOGY, 1992, 87 (03) :227-238